Follow
Christian Posch MD PhD
Christian Posch MD PhD
Head of Dermatology, Vienna Healthcare Group
Verified email at tum.de - Homepage
Title
Cited by
Cited by
Year
Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth
S Kleffel, C Posch, SR Barthel, H Mueller, C Schlapbach, E Guenova, ...
Cell 162 (6), 1242-1256, 2015
6582015
Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo
C Posch, H Moslehi, L Feeney, GA Green, A Ebaee, V Feichtenschlager, ...
Proceedings of the National Academy of Sciences 110 (10), 4015-4020, 2013
2462013
The risk of melanoma in airline pilots and cabin crew: a meta-analysis
M Sanlorenzo, MR Wehner, E Linos, J Kornak, W Kainz, C Posch, I Vujic, ...
JAMA dermatology 151 (1), 51-58, 2015
1272015
Melanoma immunotherapy
M Sanlorenzo, I Vujic, C Posch, A Dajee, A Yen, S Kim, M Ashworth, ...
Cancer biology & therapy 15 (6), 665-674, 2014
992014
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma
M Sanlorenzo, A Choudhry, I Vujic, C Posch, K Chong, K Johnston, ...
Journal of the American Academy of Dermatology 71 (6), 1102-1109. e1, 2014
912014
DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics
A Latorre, C Posch, Y Garcimartín, A Celli, M Sanlorenzo, I Vujic, J Ma, ...
Nanoscale 6 (13), 7436-7442, 2014
782014
Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer
I Vujic, M Sanlorenzo, C Posch, R Esteve-Puig, AJ Yen, A Kwong, ...
Oncotarget 6 (2), 969, 2015
752015
Mycoplasma pneumoniae‐associated mucositis – case report and systematic review of literature
I Vujic, A Shroff, M Grzelka, C Posch, B Monshi, M Sanlorenzo, ...
Journal of the European Academy of Dermatology and Venereology 29 (3), 595-598, 2015
702015
The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients
C Posch, B Monshi, T Quint, I Vujic, N Lilgenau, K Rappersberger
Journal Of The American Academy Of Dermatology 77 (1), 123-129. e5, 2017
692017
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
T Amaral, F Kiecker, S Schaefer, H Stege, K Kaehler, P Terheyden, ...
Journal for immunotherapy of cancer 8 (1), 2020
652020
Apremilast in psoriasis–a prospective real‐world study
I Vujic, R Herman, M Sanlorenzo, C Posch, B Monshi, K Rappersberger, ...
Journal of the European Academy of Dermatology and Venereology 32 (2), 254-259, 2018
642018
Combined inhibition of MEK and Plk1 has synergistic antitumor activity in NRAS mutant melanoma
C Posch, BD Cholewa, I Vujic, M Sanlorenzo, J Ma, ST Kim, S Kleffel, ...
Journal of Investigative Dermatology 135 (10), 2475-2483, 2015
612015
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
A Rogiers, IP Da Silva, C Tentori, CA Tondini, JM Grimes, MH Trager, ...
Journal for ImmunoTherapy of Cancer 9 (1), 2021
602021
Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients
B Monshi, C Posch, I Vujic, A Sesti, S Sobotka, K Rappersberger
Journal of the American Academy of Dermatology 71 (4), 738-744, 2014
582014
The burden of malignant melanoma–lessons to be learned from Austria
B Monshi, M Vujic, D Kivaranovic, A Sesti, W Oberaigner, I Vujic, ...
European journal of cancer 56, 45-53, 2016
452016
A prospective study of mobile phones for dermatology in a clinical setting
J Weingast, C Scheibböck, EMT Wurm, E Ranharter, S Porkert, S Dreiseitl, ...
Journal of telemedicine and telecare 19 (4), 213-218, 2013
452013
The risk of melanoma in pilots and cabin crew: UV measurements in flying airplanes
M Sanlorenzo, I Vujic, C Posch, JE Cleaver, P Quaglino, S Ortiz-Urda
JAMA dermatology 151 (4), 450-452, 2015
422015
Phosphoproteomic analyses of NRAS (G12) and NRAS (Q61) mutant melanocytes reveal increased CK2α kinase levels in NRAS (Q61) mutant cells
C Posch, M Sanlorenzo, I Vujic, JA Oses-Prieto, BD Cholewa, ST Kim, ...
Journal of Investigative Dermatology 136 (10), 2041-2048, 2016
372016
Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells
I Vujic, M Sanlorenzo, R Esteve-Puig, M Vujic, A Kwong, A Tsumura, ...
Oncotarget 7 (6), 7297, 2016
372016
Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients
C Posch, F Weihsengruber, K Bartsch, V Feichtenschlager, M Sanlorenzo, ...
British journal of cancer 110 (6), 1427-1432, 2014
352014
The system can't perform the operation now. Try again later.
Articles 1–20